BNRNasdaqServices-Medical Laboratories
Burning Rock Biotech Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026
$12.29−0.61 (-4.73%)
Close on Oct 19, 2026
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2025 Ended Dec 31, 2025 | Mar 13, 2026 | After market close | $126.30M | $-0.15 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 25, 2025 | Before market open | $126.00M | $-0.79 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 28, 2024 | During market hours | $121.10M | $-1.58 | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 28, 2023 | Before market open | – | – | – |
| Q2 FY2022 Ended Jun 30, 2022 | Aug 31, 2022 | Before market open | – | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Mar 22, 2022 | Before market open | – | – | – |
Press releases
Announcements Burning Rock Biotech filed with the SEC
Burning Rock Reports Second Quarter 2026 Financial Results
EX-99.1 to Form 6-K
Burning Rock Reports First Quarter 2026 Financial Results
EX-99.1 to Form 6-K
Burning Rock Announces Results of 2025 Annual General Meeting
EX-99.1 to Form 6-K
NOTICE OF ANNUAL GENERAL MEETING TO BE HELD ON DECEMBER 23, 2025
EX-99.2 to Form 6-K
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON DECEMBER 23, 2025
EX-99.3 to Form 6-K
Burning Rock Reports Third Quarter 2025 Financial Results
EX-99.1 to Form 6-K
Burning Rock Reports Second Quarter 2025 Financial Results
EX-99.1 to Form 6-K
Burning Rock Reports First Quarter 2025 Financial Results
EX-99.1 to Form 6-K
Burning Rock Announces Results of 2024 Annual General Meeting
EX-99.1 to Form 6-K
Burning Rock Reports Third Quarter 2024 Financial Results
EX-99.1 to Form 6-K
NOTICE OF ANNUAL GENERAL MEETING TO BE HELD ON DECEMBER 31, 2024
EX-99.2 to Form 6-K
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON DECEMBER 31, 2024
EX-99.3 to Form 6-K
Burning Rock Announces Changes to Management and Board of Directors
EX-99.1 to Form 6-K
Burning Rock Reports Second Quarter 2024 Financial Results
EX-99.1 to Form 6-K
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
EX-99.1 to Form 6-K
Burning Rock Reports First Quarter 2024 Financial Results
EX-99.1 to Form 6-K
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
EX-99.1 to Form 6-K
Burning Rock Announces ADS Ratio Change
EX-99.1 to Form 6-K
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
EX-99.1 to Form 6-K
Burning Rock Announces Receipt of Notification from NASDAQ
EX-99.1 to Form 6-K
Burning Rock Announces Results of 2023 Annual General Meeting
EX-99.1 to Form 6-K
Burning Rock Reports Third Quarter 2023 Financial Results
EX-99.1 to Form 6-K
NOTICE OF ANNUAL GENERAL MEETING TO BE HELD ON DECEMBER 20, 2023
EX-99.2 to Form 6-K
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON DECEMBER 20, 2023
EX-99.3 to Form 6-K
Burning Rock Reports Second Quarter 2023 Financial Results
EX-99.1 to Form 6-K
Burning Rock Announces Resignation and Appointment of Directors
EX-99.1 to Form 6-K
Burning Rock Reports First Quarter 2023 Financial Results
EX-99.1 to Form 6-K
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
EX-99.1 to Form 6-K
Burning Rock provides an update on 2022 revenue guidance
EX-99.1 to Form 6-K
Burning Rock Received FDA Breakthrough Device Designation for its OverC
EX-99.1 to Form 6-K
Burning Rock Reports Third Quarter 2022 Financial Results
EX-99.1 to Form 6-K
INDEX TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
EX-99.2 to Form 6-K